Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan
· Delayed Price · Currency is JPY 7,940.00
+495.00 (6.65%)
Apr 28, 2026, 3:30 PM JST
Chugai Pharmaceutical Revenue
Chugai Pharmaceutical had revenue of 321.75B JPY in the quarter ending March 31, 2026, with 11.54% growth. This brings the company's revenue in the last twelve months to 1.29T, up 5.65% year-over-year. In the year 2025, Chugai Pharmaceutical had annual revenue of 1.26T with 7.46% growth.
Revenue (ttm)
1,291.23B
Revenue Growth
+5.65%
P/S Ratio
10.12
Revenue / Employee
252.98M
Employees
5,104
Market Cap
13.07T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,257.94B | 87.33B | 7.46% |
| Dec 31, 2024 | 1,170.61B | 59.24B | 5.33% |
| Dec 31, 2023 | 1,111.37B | -148.58B | -11.79% |
| Dec 31, 2022 | 1,259.95B | 260.19B | 26.02% |
| Dec 31, 2021 | 999.76B | 212.81B | 27.04% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Otsuka Holdings | 2,468.89B |
| Daiichi Sankyo Company | 2,052.15B |
| Astellas Pharma | 2,060.61B |
| Kyowa Kirin | 496.83B |
| Ono Pharmaceutical | 509.35B |
| Santen Pharmaceutical | 287.99B |
| JCR Pharmaceuticals | 37.55B |
| Perseus Proteomics | 140.41M |
Chugai Pharmaceutical News
- 2 months ago - Japanese drugmakers slump after Trump unveils discount drug website - Reuters